PhuongMaiMDMS

PubMed

• Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
  Mai PL, Best AF, Peters JA, DeCastro RM, Khincha PP, Loud JT, Bremer RC, Rosenberg PS, Savage SA> ;Cancer. 2016-12-01
• Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
  Elena Vigorito, Karoline Kuchenbaecker, Jonathan Beesley, Julian Adlard, Bjarni A. Agnarsson, Irene L. Andrulis, Banu Arun, Laure Barjhoux, Muriel Belotti, Javier Beni...> ;PLOS ONE. 2016 Jul 27
• Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus
  Chenjie Zeng, Xingyi Guo, Jirong Long, Karoline Kuchenbaecker, Arnaud Droit, Kyriaki Michailidou, Maya Ghoussaini, Siddhartha Kar, Adam N. Freeman, John L. Hopper, Rog...> ;Breast Cancer Research. 2016 Jun 21
• Easing the Burden: Describing the Role of Social, Emotional and Spiritual Support in Research Families with Li-Fraumeni Syndrome.
  June A. Peters, Regina Kenen, Renee C. Bremer, Shannon Givens, Sharon A. Savage, Phuong L. Mai> ;Journal of Genetic Counseling. 2016 Jun 1
• Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene v...
  de la Hoya M, Soukarieh O, López-Perolio I, Vega A, Walker LC, van Ierland Y, Baralle D, Santamariña M, Lattimore V, Wijnen J, Whiley P, Blanco A, Raponi M, Hauke J, W...> ;Hum. Mol. Genet.. 2016-06-01
• No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
  Antoinette Hollestelle, Frederieke H. van der Baan, Andrew Berchuck, Sharon E. Johnatty, Katja K.H. Aben, Bjarni A. Agnarsson, Kristiina Aittomäki, Elisa Alducci, Iren...> ;Gynecologic Oncology. 2016 May 1
• Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
  Fergus J. Couch, Karoline Kuchenbaecker, Kyriaki Michailidou, Gustavo Mendoza-Fandino, Silje Nord, Janna Lilyquist, Curtis Olswold, Emily Hallberg, Simona Agata, Habib...> ;Nature Communications. 2016 Apr 27
• Research participant interest in primary, secondary, and incidental genomic findings.
  Jennifer T. Loud, Renee C. Bremer, Phuong L. Mai, June A. Peters, Neelam Giri, Douglas R. Stewart, Mark H. Greene, Blanche P. Alter, Sharon A. Savage> ;Genetics in Medicine. 2016 Apr 21
• Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170
  Alison M. Dunning, Kyriaki Michailidou, Karoline Kuchenbaecker, Deborah J. Thompson, Juliet D. French, Jonathan Beesley, Catherine S. Healey, Siddhartha Kar, Karen A. ...> ;Nature Genetics. 2016 Apr 1
• Male breast cancer in BRCA1 and BRCA2 mutation carriers: Pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
  Valentina Silvestri, Daniel Barrowdale, Anna Marie Mulligan, Susan L. Neuhausen, Stephen B. Fox, Beth Y. Karlan, Gillian Mitchell, Paul A. James, Darcy L. Thull, Krist...> ;Breast Cancer Research. 2016 Feb 9
• BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
  Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, Wang Q, Barrowdale D, Frost D, McGuffog L, Ellis S, Feng B, Buys SS, Hopper JL, Southey MC, Tesoriero A, James PA,...> ;J. Natl. Cancer Inst.. 2016-02-01
• Germline TP53 Variants and Susceptibility to Osteosarcoma
  Lisa Mirabello, Meredith Yeager, Phuong L. Mai, Julie M. Gastier-Foster, Richard Gorlick, Chand Khanna, Ana Patiño-García, Luis Sierrasesúmaga, Fernando Lecanda, Irene...> ;Journal of the National Cancer Institute. 2015 Jul 1
• The Fallopian Tube: from Back Stage to Center Stage
  Mark H. Greene, Phuong L. Mai> ;Cancer Prevention Research. 2015 May 1
• An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers
  Sophie Blein, Claire Bardel, Vincent Danjean, Lesley McGuffog, Sue Healey, Daniel Barrowdale, Andrew Lee, Joe Dennis, Karoline Kuchenbaecker, Penny Soucy, Mary Beth Te...> ;Breast Cancer Research. 2015 Apr 25
• Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
  Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, Mazoyer S, Chenevix-Trench G, Easton DF, Antoniou AC, Nathanson KL, Laitman Y, Kushnir A, Paluch-Shim...> ;JAMA. 2015-04-07
• Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers
  Ignacio Blanco, Karoline Kuchenbaecker, Daniel Cuadras, Xianshu Wang, Daniel Barrowdale, Gorka Ruiz de Garibay, Pablo Librado, Alejandro Sánchez-Gracia, Julio Rozas, N...> ;PLOS ONE. 2015 Apr 1
• Reply to M.J. Mourits et al
  Mark E. Sherman, Marion Piedmonte, Phuong L. Mai, Mark H. Greene> ;Journal of Clinical Oncology. 2015 Mar 2
• Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer
  Francisco José Candido-dos-Reis, Honglin Song, Ellen L. Goode, Julie M. Cunningham, Brooke L. Fridley, Melissa C. Larson, Kathryn Alsop, Ed Dicks, Patricia Harrington,...> ;Clinical Cancer Research. 2015 Feb 1
• Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
  Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, Coetzee S, Haz...> ;Nat. Genet.. 2015-02-01
• Familial testicular germ cell tumors (FTGCT) - overview of a multidisciplinary etiologic study.
  Mark H. Greene, P. L. Mai, Jennifer T. Loud, Anand Pathak, J. A. Peters, Lisa Mirabello, Mary L. McMaster, P. Rosenberg, Douglas R. Stewart> ;Journal of Andrology. 2015 Jan 1
• Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
  Paolo Peterlongo, Jenny Chang-Claude, Kirsten B. Moysich, Anja Rudolph, Rita K. Schmutzler, Jacques Simard, Penny Soucy, Rosalind A. Eeles, Douglas F. Easton, Ute Hama...> ;Cancer Epidemiology, Biomarkers & Prevention. 2015 Jan 1
• Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
  Karoline Kuchenbaecker, Susan L. Neuhausen, Mark E. Robson, Daniel Barrowdale, Lesley McGuffog, Anna Marie Mulligan, Irene L. Andrulis, Amanda B. Spurdle, Marjanka K. ...> ;Breast Cancer Research. 2014 Dec 31
• Effects of false-positive cancer screenings and cancer worry on risk-reducing surgery among BRCA1/2 carriers.
  David B. Portnoy, Jennifer T. Loud, Paul K. J. Han, Phuong L. Mai, Mark H. Greene> ;Health Psychology. 2014 Nov 30
• Pathologic Findings at Risk-Reducing Salpingo-Oophorectomy: Primary Results From Gynecologic Oncology Group Trial GOG-0199
  Mark E. Sherman, Marion Piedmonte, Phuong L. Mai, Olga B. Ioffe, Brigitte M. Ronnett, Linda Van Le, Iouri Ivanov, Maria C. Bell, Stephanie V. Blank, Paul DiSilvestro, ...> ;Journal of Clinical Oncology. 2014 Oct 10
• Relationships between computer-extracted mammographic texture pattern features and BRCA1/2 mutation status: a cross-sectional study.
  Gretchen L. Gierach, Hui Li, Jennifer T. Loud, Mark H. Greene, Catherine Chow, Li Lan, Sheila A. Prindiville, Jennifer Eng-Wong, Peter W. Soballe, Claudia Giambartolom...> ;Breast Cancer Research. 2014 Aug 23
• Join now to see all